Product
GlucaGen
Name
GlucaGen
INN Name
glucagon hydrochloride
FDA Approved
Yes
2 clinical trials
1 organization
4 indications
1 document
Indication
Diabetes MellitusIndication
Type 1Indication
Type 1 DiabetesIndication
HypoglycemiaClinical trial
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System; a Feasibility StudyStatus: Withdrawn, Estimated PCD: 2023-12-29
Clinical trial
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 DiabetesStatus: Recruiting, Estimated PCD: 2024-05-13
Document
DailyMed Label: GlucaGenOrganization
Boehringer Ingelheim Pharmaceuticals, Inc.